Literature DB >> 12709814

Polymorphisms of tumor necrosis factor (TNF) alpha and beta genes in Korean patients with psoriasis.

Tai-Gyu Kim1, Chul-Woo Pyo, Sung-Suk Hur, Yang-Kyum Kim, Ha-Young Hwang, Jai-Il Youn, Tae-Yoon Kim.   

Abstract

To evaluate the association of TNF-alpha (TNFA) and TNF-beta (TNFB) polymorphisms with psoriasis in the Korean population, we investigated TNF-alpha -238 and -308 promoter region and TNF-beta NcoI polymorphism using PCR-RFLP in 103 Korean psoriasis patients and 125 normal controls. The carriage and allele frequencies of TNFB*2 were significantly increased in patients with psoriasis compared with normal controls. However, TNFB*1/1 homozygote and TNFB*1 allele were significantly decreased in the patients. There were no significant differences in the polymorphism of TNF-alpha promoter -238 and -308 between the patients and controls. We also analyzed the frequencies of TNFB alleles according to the clinical characteristics of the psoriasis patients, but no significant differences were found. However, female patients with early-onset psoriasis showed an association with the TNFB*2 allele. In conclusion, our results suggest that polymorphisms of the TNFB gene may contribute to a predisposition to psoriasis in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709814     DOI: 10.1007/s00403-003-0392-9

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

Review 1.  The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

Authors:  Marina Talamonti; Simone D'Adamio; Luca Bianchi; Marco Galluzzo
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

Review 2.  [Molecular genetic basis of predisposition to psoriasis].

Authors:  E S Galimova; V L Akhmetova; E K Khusnutdinova
Journal:  Genetika       Date:  2008-05

3.  Associations between TNF-α-308A/G polymorphism and susceptibility with dermatomyositis: a meta-analysis.

Authors:  Si Chen; Qian Wang; Ziyan Wu; Qingjun Wu; Ping Li; Yuan Li; Jing Li; Chuiwen Deng; Chanyuan Wu; Lei Gao; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

4.  Association of the TNF-α, IL-2, and IL-2RB gene variants with susceptibility to psoriasis in a Turkish cohort.

Authors:  Aslihan Gulel; Huseyin Serhat Inaloz; Ayse Feyda Nursal; Tugce Sever; Sacide Pehlivan
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

5.  Single nucleotide polymorphisms in the tumor necrosis factor-alpha gene promoter region alter the risk of psoriasis vulgaris and psoriatic arthritis: a meta-analysis.

Authors:  Junqing Zhu; Hongda Qu; Xiaoguang Chen; Hao Wang; Juan Li
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

6.  A Comprehensive Study of Tumor Necrosis Factor-Alpha Genetic Polymorphisms, its Expression in Skin and Relation to Histopathological Features in Psoriasis.

Authors:  Nikhil N Moorchung; Biju Vasudevan; Manas Chatterjee; Rajan Singh Grewal; Narayana S Mani
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

Review 7.  Genetics of psoriasis and pharmacogenetics of biological drugs.

Authors:  Rocío Prieto-Pérez; Teresa Cabaleiro; Esteban Daudén; Dolores Ochoa; Manuel Roman; Francisco Abad-Santos
Journal:  Autoimmune Dis       Date:  2013-08-28

8.  Associations between tumor necrosis factor-α polymorphisms and risk of psoriasis: a meta-analysis.

Authors:  Le Zhuang; Weiyuan Ma; Daxing Cai; Hua Zhong; Qing Sun
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

9.  TNF-308 G/A polymorphism and risk of acne vulgaris: a meta-analysis.

Authors:  Jian-Kang Yang; Wen-Juan Wu; Jue Qi; Li He; Ya-Ping Zhang
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  Tumor Necrosis Factor-α 308 G/A polymorphism and psoriasis risk: A pooled analysis in different populations.

Authors:  Cuicui Shen; Haiyan Wang; Qunxian Song; Bing Zhang; Xuewei Liu; Jianwei Li
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.